The histopathology, "white matter spongiosis," defined by electron microscopy (EM) as "intramyelinic edema," has been associated with vigabatrin therapy in various animal models, but its role or significance in clinical studies is unknown.
Summary
The histopathology, "white matter spongiosis," defined by electron microscopy (EM) as "intramyelinic edema," has been associated with vigabatrin therapy in various animal models, but its role or significance in clinical studies is unknown.
We conducted a neuropathological examination on a 27-month-old boy with bilateral polymicrogyria and epilepsy after sudden unexpected death in epilepsy (SUDEP). The patient was initiated on vigabatrin at 4 months of age, which controlled infantile spasms, and was continued as maintenance therapy. Autopsy showed a combination of developmental and acquired lesions: (1) bilateral gyral malformations of the frontal, parietal, temporal, and insular cortex; (2) agenesis of the olfactory tracts and bulbs; (3) hippocampal abnormalities: dentate gyrus bilamination and granule cell dispersion; and (4) areas of microscopic bilateral, symmetric white matter spongiosis in the brainstem central tegmental tract, amiculum and hilum of the inferior olive, medial longitudinal fasciculus, paragigantocellularis lateralis, optic nerves and chiasm, and hypothalamus. The white matter spongiosis was identical to the histopathologic lesions (which by EM exhibited intramyelinic edema) that were demonstrated in animal models on vigabatrin therapy, indicating that vigabatrin toxicity is not restricted to animal models.
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| INTRODUCTION
Vigabatrin is an irreversible inhibitor of c-aminobutyric acid (GABA) transaminase that is used clinically for the treatment of focal-onset seizures and infantile spasms, particularly for patients with tuberous sclerosis. Use has been limited due to retinal cone dysfunction and, in some cases, visual field constriction. 1 In addition, vigabatrin can be associated with magnetic resonance imaging (MRI) T2-weighted hyperintensities and restricted diffusion in the basal ganglia, thalami, brainstem, and cerebellar dentate nuclei. 2 Suggested risk factors are age, dosage, and possibly concomitant hormonal therapy. 3 Preclinical toxicity studies have shown that long-term administration of vigabatrin produces cerebral intramyelinic edema by electron microscopy (EM) in various species, including rats, mice, and dogs. [4] [5] [6] Lesions were characterized with EM by 10-100 lm diameter vacuolation in white matter caused by fluid accumulation and separation of the intraperiod line, that is, lamellae located between the outer protein coats of the myelin sheath. By light microscopy, the vacuoles are characteristic in histology, reflecting the EM and topography that are similar to those in our patient. The lesions have been bilateral in all species studied, and areas predominantly involved are central white matter tracts, sparing the spinal cord and peripheral nerves. Both dosage and duration appear to be risk factors. 5, 7 Surveillance of clinical experience of an estimated 350 000 patient-years of vigabatrin exposure, including studies of evoked potentials, MRI, and histopathological specimens, did not identify evidence of vacuoles/intramyelinic edema occurring in humans exposed to doses used for treatment of epilepsy. 8 The latter included review of 24 autopsy cases with protocols designed to minimize postmortem and processing artifact and utilizing immunohistochemical techniques to detect reactive astrocytes and axonal damage. There was a separate report of a 10-monthold former 29-week premature infant with a history of hypoxic ischemic brain injury, preexisting white matter abnormalities, and infantile spasms who was treated with vigabatrin and deteriorated neurologically 3 days after the therapy was introduced and died of bronchopneumonia 3 weeks later. Postmortem examination showed histological vacuolization and EM intramyelinic edema in the central white matter. 9 After the unexpected death of a 27-month-old boy with bilateral polymicrogyria (PMG) and epilepsy who had been receiving vigabatrin therapy for 13 months, a neuropathological examination was conducted that identified white matter spongiosis identical to that seen in animal models.
| METHODS
History and imaging were reviewed by the treating pediatric epileptologist and by Robert's Program for Sudden Unexpected Death in Childhood (Boston Children's Hospital). 10 Initial gross and microscopic postmortem examination was done through the Office of the Chief Medical Examiner (Boston, MA, USA) and members of Robert's Program. Trio exome sequencing on DNA obtained from the child's spleen was performed at the Broad Institute (Cambridge, MA, USA) using a standard Illumina platform. We analyzed for rare, protein-altering, de novo, homozygous, or compound heterozygous variants in all genes as well as any variants, including inherited variants in a curated list of genes associated with epilepsy, cardiac arrhythmia, and sudden death.
| CLINICAL DESCRIPTION
The proband died at age 27 months due to SUDEP (sudden unexpected death in epilepsy), with a history of neurodevelopmental impairment and epilepsy related to bilateral PMG. He was the product of an unremarkable gestation to a 33-year-old G3P1 mother. Cesarean section was done 10 days post-dates because of failure to progress and maternal fever. Neonatal sepsis evaluation was negative, and the newborn course was unremarkable. Seizure onset occurred at 3 months as generalized myoclonic and right extremity focal motor seizures. He had normal growth, with weight 7.46 kg, length 67 cm, and head circumference 43 cm, all at the 90%-95% percentile. Neurological examination was normal for age. He was treated sequentially with phenobarbital, oxcarbazepine, and levetiracetam, but hospitalized at age 4 months with developmental regression and infantile spasms. MRI showed extensive bilateral perisylvian PMG, with the left hemisphere more affected than the right (Figure 1 ). Chromosomal microarray with resolution of 50 kb and a sequencing panel targeting genes associated with PMG (University of Chicago 2014) were negative.
Vigabatrin was initiated at age 4 months; seizures ceased and developmental progress occurred with increasing alertness, spontaneous and responsive smile, visual with seizure resolution for 2 months. Developmentally, the patient was walking independently; he remained nonverbal but displayed good socialization. No sleep difficulties were noted. Between ages 25 and27 months, he had relatively good seizure control with occasional myoclonic seizures.
He was found at a normal check time in the prone position, apneic, and immobile, 5 hours after having been placed in his crib for overnight sleep. Nothing was covering the nose or mouth. There was no frothy fluid around the nose. There was no history of systemic symptoms or seizure exacerbation in the 3 days before death.
| RESULTS
Major gyral maldevelopment was demonstrated bilaterally, with PMG of the orbitofrontal lobes bilaterally, left greater than right; thick, broadened parietal gyri; asymmetry of the lateral temporal lobes, with thick gyri perpendicular to the Sylvian fissure on the left and jumbled gyri of the medial temporal lobe on the right; open anterior operculum of right side; and asymmetry of the insula with slightly excess gyri bilaterally. There was bilateral agenesis of the olfactory tracts and bulbs. There were also abnormal hippocampi with granule cell dispersion, bilamination of the dentate gyrus, and heterotopic granule cells in the molecular layer and hilum of the dentate gyrus. Microdysgenetic features demonstrated fused pyramids in the medulla oblongata and hamartia in layer II of temporal cortex overlying the amygdala.
Bilateral, symmetric vacuolation (spongiosis) of white matter tracts was identified, involving the central tegmental tract, optic nerves and chiasm, hilum and amiculum of inferior olive, hypothalamus, and medial longitudinal fasciculus (Figure 2 ). The vacuoles (1-100 microns in diameter) were characterized by myelin splitting and round cavities without axonal spheroids, gliosis, or microglial reaction in white matter tracts. Properly fixed tissue at autopsy for EM of the light microscopic vacuoles was not available in our case and EM was not performed. Nuclei involving cardiorespiratory function were generally unremarkable, including the nucleus of the solitary tract, hypoglossal nucleus, and dorsal motor tract of the vagus. The gigantocellularis and | paragigantocellularis lateralis (PGCL), however, contained vacuoles in the medullary reticular formation. The putative human homologue of the pre-B€ otzinger complex, that is, the central rhythm generator, is thought to be localized to the PGCL. 11 There was no gliosis, neuroaxonal loss, or axonal spheroids in these regions. There was no pseudohypertrophy of the inferior olive. The cerebellum and tracts were intact. Exome sequencing data did not identify any gene variant that explained the brain malformation or sudden death.
| DISCUSSION
We describe spongiform lesions of the myelinated tracts of the brainstem and deep forebrain, consistent with the known exposure to vigabatrin, in a young child with PMG and infantile epilepsy who died unexpectedly during a period of seizure control.
The histopathology in our patient is identical to histopathology reported in animals exposed to vigabatrin. 8 In animals, EM reveals 1-100 micron in diameter vacuoles, which are thought to be fluid filled and result in separation of the outer layers of myelin at the intraperiod line. In experimental animals, bilateral lesions are seen in the columns of the fornix and regions of the thalamus, hypothalamus, optic tracts, and brainstem; our case involves the latter 3. A single previously reported pediatric case of EM intramyelinic edema showed on light microscopy vacuolization that resembles the findings in this case. Many of the affected regions are similar, and there was no astrocytosis or activation of microglia or axonal swelling in either case. 9 The previous case, a premature with delayed myelination, had acute encephalopathy 3 days after initiation of vigabatrin and died following 3 weeks of discontinuous therapy with a maximum dose of 50 mg kg À1 d À1 . This is in contrast to our case of a toddler with a sustained period, from 4 to 27 months of age, of vigabatrin therapy used as a maintenance antiseizure medicine on a standard dose (125-140 mg kg À1 d À1 ) and an otherwise stable clinical course. The pathophysiologic mechanism of the development of the myelin lesions is unknown. Direct toxicity to the myelinforming oligodendrocyte was not demonstrated in myelinated rat cerebellar cultures at very high vigabatrin and GABA concentrations. 12 Other GABA-transaminase inhibitors have been shown to induce microvacuolation in similar anatomic locations, although the findings are less severe following ethanolamine-O-sulphate than vigabatrin, suggesting that increased brain GABA is not the sole or direct mechanism. 13 Neuropathology in the disorder succinic semialdehyde dehydrogenase (SSADH) deficiency, associated with supraphysiologic GABA levels, does not show intramyelinic edema. 14 An explanation may be in the essential role recently demonstrated for GABA transaminase in mitochondrial metabolism, specifically in the conversion of deoxy-nucleotide diphosphate (dNDP) to deoxy-nucleotide triphosphate (dNTP) in the nucleoside salvage pathway. GABA transaminase inhibition was demonstrated to cause decreased copy number of mitochondrial DNA (mtDNA)-utilizing fibroblasts from subjects with GABA transaminase deficiency and via genetic degradation technology in healthy fibroblasts. This same effect was induced using vigabatrin, and furthermore demonstrated to be reversible in vitro using dNTP supplementation. 15 The clinical significance of the spongiform white matter lesions in our patient is unknown. Their location in the brainstem, and in particular, in the PGCL, raises the question of whether these lesions may have contributed to the sudden death via a respiratory-related apnea or other breathing irregularity. Although there was no somatic cause of death found after complete general autopsy, it is noteworthy that there were also asymmetric insulae with excessive gyri. The insular cortex is known to be involved in cardiorespiratory control and to contain a viscerotopic map of the autonomic nervous system; insular strokes have been associated with breathing problems and sudden death. 16 The white matter spongiosis detected on postmortem examination is histopathologically identical to the vigabatrin-induced spongiosis associated with intramyelinic edema in experimental models. Our observations establish that spongiosis consistent with intramyelinic edema occurs in human subjects treated with vigabatrin for infantile spasms.
